Case 31

Patient #31 was 60 years old with a past medical history of hypertension, hyperlipidemia, and systemic lupus erythematosus who presented to the emergency department on 24Sept2020 with shortness of breath and a diagnosis of Covid19 from 19Sept2020. The patient was started on prednisone with minimal improvement. The chest x-ray on 24Sept2020 demonstrated bilateral infiltrates. Sputum cultures on 28Sept2020 and 08Oct2020 were positive for CRAB resistant to all antibiotics but had intermediate susceptibility to tigecycline. Phage treatment was initiated on 01Oct2020 and administered twice a day for 2 weeks. Blood cultures on 24Sept2020 and 09Oct2020 were negative. Sputum cultures were negative on 03Oct2020, 04Oct2020, 07Oct2020, and 10Oct2020. No adverse events were reported as related to phage therapy. The patient expired on 15Oct2020.